These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 19491813)

  • 1. [Somatic pathology and causes of death in schizophrenia].
    Volkov VP
    Zh Nevrol Psikhiatr Im S S Korsakova; 2009; 109(5):14-9. PubMed ID: 19491813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [About secondary phenothiazine-induced cardiomyopathy].
    Klin Med (Mosk); 2011; 89(5):30-3. PubMed ID: 22242263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Respiratory diseases as a cause of death in schizophrenia].
    Volkov VP
    Probl Tuberk Bolezn Legk; 2009; (6):24-7. PubMed ID: 19645113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Piperacetazine in ambulatory chronic schizophrenic patients.
    Rada RT; Donlon PT
    Curr Ther Res Clin Exp; 1974 Feb; 16(2):124-9. PubMed ID: 4156665
    [No Abstract]   [Full Text] [Related]  

  • 5. [Peculiarities of ECG in patients with phenothiazine-induced cardiomyopathy].
    Volkov VP
    Klin Med (Mosk); 2011; 89(4):27-30. PubMed ID: 21932558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Phenothiazine-induced dilatation cardiomyopathy: selected aspects of clinical course and morphology].
    Volkov VP
    Klin Med (Mosk); 2009; 87(8):13-6. PubMed ID: 19827523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An uncontrolled clinical study with piperacetazine in the maintenance treatment of chronic schizophrenic patients.
    Amin MM; Brahm E; Ban TA; Lehmann HE
    Psychopharmacol Bull; 1977 Jul; 13(3):10-1. PubMed ID: 18753
    [No Abstract]   [Full Text] [Related]  

  • 8. [Ischemic heart disease in patients with schizophrenia (clinico-epidemiological study)].
    Syrkin AL; Smulevich AB; Novikova NA; Bocharova MV; Drobizhev MIu; Baturin KA
    Kardiologiia; 2007; 47(3):19-24. PubMed ID: 17495845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High dosage piperacetazine (Quide) in ambulatory schizophrenic patients--therapeutic efficacy and toxicity.
    Donlon PT; Rada RT
    Dis Nerv Syst; 1974 May; 35(5):231-6. PubMed ID: 17894106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antipsychotic polypharmacy and risk of death from natural causes in patients with schizophrenia: a population-based nested case-control study.
    Baandrup L; Gasse C; Jensen VD; Glenthoj BY; Nordentoft M; Lublin H; Fink-Jensen A; Lindhardt A; Mortensen PB
    J Clin Psychiatry; 2010 Feb; 71(2):103-8. PubMed ID: 19895781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiac injury is a common postmortem finding in thrombotic thrombocytopenic purpura patients: is empiric cardiac monitoring and protection needed?
    Nichols L; Berg A; Rollins-Raval MA; Raval JS
    Ther Apher Dial; 2015 Feb; 19(1):87-92. PubMed ID: 25196220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of phenothiazine drugs on serum levels of apolipoproteins and lipoproteins in schizophrenic subjects.
    Wen F; Tan J
    Acta Pharmacol Sin; 2003 Oct; 24(10):1001-5. PubMed ID: 14531942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical evaluation of pipothiazine and its palmitic ester in the therapy of schizophrenia].
    Costa JG; Silva E; Dreyfus JF
    Ann Med Psychol (Paris); 1981 Apr; 139(4):439-45. PubMed ID: 6118086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenothiazine deaths: a critical review.
    Peele R; Von Loetzen IS
    Am J Psychiatry; 1973 Mar; 130(3):306-9. PubMed ID: 4143945
    [No Abstract]   [Full Text] [Related]  

  • 15. [What is behind phenotiazinic cardiomyopathy?].
    Bel'diev SN
    Klin Med (Mosk); 2011; 89(2):63-4. PubMed ID: 21574449
    [No Abstract]   [Full Text] [Related]  

  • 16. Do atypical antipsychotic drugs reduce the risk of ischemic heart disease and mortality? Possible role of 5-HT2A receptor blockade.
    Blasco-Fontecilla H; Baca-Garcia E; de Leon J
    Schizophr Res; 2010 Jun; 119(1-3):160-3. PubMed ID: 20053538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preliminary experience in the treatment of schizophrenia with pipothiazine and its derivatives.
    Faltus F; Marecek P; Soucek K
    Act Nerv Super (Praha); 1975 Sep; 17(3):204. PubMed ID: 883
    [No Abstract]   [Full Text] [Related]  

  • 18. A long-term pilot study of pipothiazine palmitate in chronic schizophrenia.
    Villeneuve A; Pires A; Jus A; Lachance R; Drolet A
    Curr Ther Res Clin Exp; 1972 Nov; 14(11):696-706. PubMed ID: 4404626
    [No Abstract]   [Full Text] [Related]  

  • 19. Sudden unexpected death in schizophrenia: autopsy findings in psychiatric inpatients.
    Ifteni P; Correll CU; Burtea V; Kane JM; Manu P
    Schizophr Res; 2014 May; 155(1-3):72-6. PubMed ID: 24704220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Development of forensic thanatology through the prism of analysis of postmortem protocols collected at the Department of Forensic Medicine, Jagiellonian University].
    Konopka T
    Arch Med Sadowej Kryminol; 2011; 61(3):213-300. PubMed ID: 22393873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.